Fig. 1
Patient Enrollment Flowchart. TACE, transarterial chemoembolization; LEN-TAP, lenvatinib-TACE–anti-PD-1 inhibitor combination therapy
Fig. 1 | Signal Transduction and Targeted Therapy
Patient Enrollment Flowchart. TACE, transarterial chemoembolization; LEN-TAP, lenvatinib-TACE–anti-PD-1 inhibitor combination therapy
